[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Medicated Skin Care in Nigeria

July 2012 | 25 pages | ID: ME01548FEA0EN
Euromonitor International Ltd

US$ 990.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Medicated skin care produced a significant growth rate in 2011. While producers promoted their products with improved marketing activities, the fast growing young and health conscious consumer groups also helped the category achieve such good positive growth in 2011. As disposable income grows due to economic recovery, consumers are spending more on skin care products, which they had hitherto considered non-essential.

Euromonitor International's Medicated Skin Care in Nigeria report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2007-2011, allowing you to identify the sectors driving growth. Forecasts to 2016 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Medicated Skin Care, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Medicated Skin Care market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
MEDICATED SKIN CARE IN NIGERIA

Euromonitor International
July 2012

LIST OF CONTENTS AND TABLES

Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
  Table 1 Sales of Medicated Skin Care by Category: Value 2006-2011
  Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  Table 3 Medicated Skin Care Company Shares by Value 2007-2011
  Table 4 Medicated Skin Care Brand Shares 2008-2011
  Table 5 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  Table 6 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016
Neimeth International Pharmaceuticals Plc in Consumer Health (nigeria)
Strategic Direction
Key Facts
  Summary 1 Neimeth International Pharmaceuticals Plc: Key Facts
  Summary 2 Neimeth International Pharmaceuticals Plc: Operational Indicators
Company Background
Production
Competitive Positioning
  Summary 3 Neimeth International Pharmaceuticals Plc: Competitive Position 2011
Executive Summary
Consumer Health Records Its Strongest Value Growth in Over Five Years
Rising Health Awareness Drives Sales of Vitamins and Dietary Supplements
Emzor Pharmaceutical and GlaxoSmithKline Lead in Core Market Categories
Sales Growth Through Non-specialist Retail Channels
Forecast Period Growth Expected To Be Stronger Than in the Review Period
Key Trends and Developments
Urbanisation Is Growing Rapidly
Economic Growth, But Growth Slower Than Expected in the Middle Class
Increased Spending on Health Goods and Medical Services
Increase in Health and Wellness Consciousness
Number of Babies/infants Increases Despite Declining Fertility and Birth Rates
Market Indicators
  Table 7 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  Table 8 Life Expectancy at Birth 2006-2011
Market Data
  Table 9 Sales of Consumer Health by Category: Value 2006-2011
  Table 10 Sales of Consumer Health by Category: % Value Growth 2006-2011
  Table 11 Consumer Health Company Shares 2007-2011
  Table 12 Consumer Health Brand Shares 2008-2011
  Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  Table 15 Forecast Sales of Consumer Health by Category: Value 2011-2016
  Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventative Medicine
Switches
Sources
  Summary 4 Research Sources


More Publications